63 results
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction … such further inquiry or investigation into such facts or matters as it may see fit.
(h) The Trustee shall not be deemed to have notice of any Default
8-K
EX-10.2
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
as could not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received notice of any investigation … or notice of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any Subsidiary, except
8-K
EX-10.1
zo33jbm kx73
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
5e51wrxh xx
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
503fl8a k2tpt88mi
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
cpq23lkgmijv
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.3
xnrbw
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.1
lb44 hh4c2
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
zytwtj7ve3hqt9l
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-1.1
x8qj0w0cgdt137
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.1
qey msekjag5a8ega5
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-4.2
g1nx fhdhe1i4knmpz63
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
wphv 4p2xo
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
00vj7ifv
28 Mar 22
Prospectus supplement for primary offering
4:53pm